Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Publisher Correction: Analysis of the serial circulating tumor cell count during neoadjuvant chemotherapy in breast cancer patients.
Gwark S, Kim J, Kwon NJ, Kim KY, Kim Y, Lee CH, Kim YH, Kim MS, Hong SW, Choi MY, Jeon BH, Chang S, Yu J, Park JY, Lee HJ, Lee SB, Chung IY, Ko BS, Kim HJ, Lee JW, Son BH, Ahn JH, Jung KH, Kim SB, Gong GY, Ahn SH. Gwark S, et al. Sci Rep. 2021 Mar 11;11(1):6148. doi: 10.1038/s41598-021-85731-3. Sci Rep. 2021. PMID: 33707602 Free PMC article. No abstract available.
Risk stratification system for groups with a low, intermediate, and high risk of subsequent distant metastasis and death following isolated locoregional recurrence of breast cancer.
Lee YJ, Park H, Kang CM, Gwark SC, Lee SB, Kim J, Chung IY, Ko BS, Kim HJ, Kim SB, Ahn SD, Gong G, Son BH, Ahn SH, Lee JW. Lee YJ, et al. Breast Cancer Res Treat. 2020 Jan;179(2):315-324. doi: 10.1007/s10549-019-05469-5. Epub 2019 Oct 23. Breast Cancer Res Treat. 2020. PMID: 31642987
The effects of poloxamer and sodium alginate mixture (Guardix-SG®) on range of motion after axillary lymph node dissection: A single-center, prospective, randomized, double-blind pilot study.
Lee SB, Gwark SC, Kang CM, Sohn G, Kim J, Chung IY, Lee JW, Kim HJ, Ko BS, Ahn SH, Kim W, Do J, Jeon JY, Kim J, Um E, Yoon TI, Jung SU, Han M, Son BH. Lee SB, et al. PLoS One. 2020 Sep 23;15(9):e0238284. doi: 10.1371/journal.pone.0238284. eCollection 2020. PLoS One. 2020. PMID: 32966294 Free PMC article. Clinical Trial.
Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer.
Gwark S, Ahn SH, Noh WC, Lee ES, Jung Y, Kim LS, Han W, Nam SJ, Gong G, Kim SO, Kim HJ. Gwark S, et al. Front Oncol. 2021 Jul 2;11:608207. doi: 10.3389/fonc.2021.608207. eCollection 2021. Front Oncol. 2021. PMID: 34277393 Free PMC article.
Axillary Lymph Node Dissection Rates and Prognosis From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer.
Gwark S, Noh WC, Ahn SH, Lee ES, Jung Y, Kim LS, Han W, Nam SJ, Gong G, Kim SO, Kim HJ. Gwark S, et al. Front Oncol. 2021 Sep 30;11:741120. doi: 10.3389/fonc.2021.741120. eCollection 2021. Front Oncol. 2021. PMID: 34660302 Free PMC article.
16 results